TrademarkDir
ASPECT PHARMACEUTICALS
DEAD

Serial Number

86913132

Owner

Aspect Pharmaceuticals, LLC

Attorney

Joseph C. Guagliardo

Filing Date

Feb 19, 2016

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

ASPECT PHARMACEUTICALS Trademark

Serial Number: 86913132

ASPECT PHARMACEUTICALS is a trademark filed by Aspect Pharmaceuticals, LLC on February 19, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Aspect Pharmaceuticals, LLC (6 trademarks)

4351 East Lohman Avenue, Suite 208
Las Cruces, NM 88011

Entity Type: 16

Trademark Details

Filing Date

February 19, 2016

Registration Date

Not Registered

Published for Opposition

April 24, 2018

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jul 26, 2021 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jul 26, 2021 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 13, 2021 EXRA
SOU EXTENSION 5 GRANTED
Jan 12, 2021 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 11, 2021 AITU
SOU EXTENSION 5 FILED
Dec 20, 2020 EXT5
SOU TEAS EXTENSION RECEIVED
Dec 20, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 20, 2020 EXRA
SOU EXTENSION 4 GRANTED
Jun 18, 2020 EX4G
SOU EXTENSION 4 FILED
Jun 18, 2020 EXT4
SOU TEAS EXTENSION RECEIVED
Jun 18, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 20, 2019 EXRA
SOU EXTENSION 3 GRANTED
Dec 18, 2019 EX3G
SOU EXTENSION 3 FILED
Dec 18, 2019 EXT3
SOU TEAS EXTENSION RECEIVED
Dec 18, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 20, 2019 EXRA
SOU EXTENSION 2 GRANTED
Jun 18, 2019 EX2G
SOU EXTENSION 2 FILED
Jun 18, 2019 EXT2
SOU TEAS EXTENSION RECEIVED
Jun 18, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 21, 2018 EXRA
SOU EXTENSION 1 GRANTED
Dec 19, 2018 EX1G
SOU EXTENSION 1 FILED
Dec 19, 2018 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 19, 2018 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 19, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 24, 2018 NPUB
PUBLISHED FOR OPPOSITION
Apr 24, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 4, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 19, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 19, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 19, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 19, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 19, 2018 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 14, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 13, 2018 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 13, 2018 ERFR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 13, 2018 TCCA
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 14, 2017 GNFN
FINAL REFUSAL E-MAILED
Sep 14, 2017 GNFR
FINAL REFUSAL WRITTEN
Sep 14, 2017 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 3, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 3, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 3, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 3, 2017 GNRN
NON-FINAL ACTION E-MAILED
Feb 3, 2017 GNRT
NON-FINAL ACTION WRITTEN
Feb 3, 2017 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 15, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 14, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 14, 2016 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 14, 2016 GNRN
NON-FINAL ACTION E-MAILED
Jun 14, 2016 GNRT
NON-FINAL ACTION WRITTEN
Jun 14, 2016 CNRT
ASSIGNED TO EXAMINER
Jun 6, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 25, 2016 NWOS
NEW APPLICATION ENTERED
Feb 23, 2016 NWAP

Related Trademarks

More from this Owner

SKINDORPHINS

SKINDORPHINS

SKINDORPHINS

SKINDORPHINS

SKINDORPHINS

SKINDORPHINS

ASPECT PHARMACEUTICALS

ASPECT PHARMACEUTICALS

ASPECT PHARMACEUTICALS

ASPECT PHARMACEUTICALS

ASPECT PHARMACEUTICALS

ASPECT PHARMACEUTICALS